190 related articles for article (PubMed ID: 10706110)
1. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.
Guillemette C; Millikan RC; Newman B; Housman DE
Cancer Res; 2000 Feb; 60(4):950-6. PubMed ID: 10706110
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans.
Huo D; Kim HJ; Adebamowo CA; Ogundiran TO; Akang EE; Campbell O; Adenipekun A; Niu Q; Sveen L; Fackenthal JD; Fackenthal DL; Das S; Cox N; Di Rienzo A; Olopade OI
Breast Cancer Res Treat; 2008 Jul; 110(2):367-76. PubMed ID: 17909964
[TBL] [Abstract][Full Text] [Related]
3. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.
Guillemette C; De Vivo I; Hankinson SE; Haiman CA; Spiegelman D; Housman DE; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):711-4. PubMed ID: 11401924
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer.
Adegoke OJ; Shu XO; Gao YT; Cai Q; Breyer J; Smith J; Zheng W
Breast Cancer Res Treat; 2004 Jun; 85(3):239-45. PubMed ID: 15111762
[TBL] [Abstract][Full Text] [Related]
5. UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients.
Sparks R; Ulrich CM; Bigler J; Tworoger SS; Yasui Y; Rajan KB; Porter P; Stanczyk FZ; Ballard-Barbash R; Yuan X; Lin MG; McVarish L; Aiello EJ; McTiernan A
Breast Cancer Res; 2004; 6(5):R488-98. PubMed ID: 15318931
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women.
Tsezou A; Tzetis M; Giannatou E; Gennatas C; Pampanos A; Kanavakis E; Kitsiou-Tzeli S
Genet Test; 2007; 11(3):303-6. PubMed ID: 17949292
[TBL] [Abstract][Full Text] [Related]
7. [Association of polymorphisms in SULT1A1 and UGT1A1 Genes with breast cancer risk and phenotypes in Russian women].
Shatalova EG; Loginov VI; Braga EA; Kazubskaia TP; Sudomoina MA; Blanchard RL; Favorova OO
Mol Biol (Mosk); 2006; 40(2):263-70. PubMed ID: 16637266
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of the
Smith A; Cropp CD; Vidal G; Pritchard E; Cordero J; Simpson C; Starlard-Davenport A
Cancer Health Disparities; 2019 Aug; 3():e1-e12. PubMed ID: 31485577
[TBL] [Abstract][Full Text] [Related]
9. The functional UGT1A1 promoter polymorphism decreases endometrial cancer risk.
Duguay Y; McGrath M; Lépine J; Gagné JF; Hankinson SE; Colditz GA; Hunter DJ; Plante M; Têtu B; Bélanger A; Guillemette C; De Vivo I
Cancer Res; 2004 Feb; 64(3):1202-7. PubMed ID: 14871858
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in human SULT1A1 and UGT1A1 genes associate with breast tumor characteristics: a case-series study.
Shatalova EG; Walther SE; Favorova OO; Rebbeck TR; Blanchard RL
Breast Cancer Res; 2005; 7(6):R909-21. PubMed ID: 16280036
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver.
Li Y; Buckley D; Wang S; Klaassen CD; Zhong XB
Drug Metab Dispos; 2009 Sep; 37(9):1978-86. PubMed ID: 19541828
[TBL] [Abstract][Full Text] [Related]
12. Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer.
Bajro MH; Josifovski T; Panovski M; Jankulovski N; Nestorovska AK; Matevska N; Petrusevska N; Dimovski AJ
Cancer Genet; 2012 Apr; 205(4):163-7. PubMed ID: 22559977
[TBL] [Abstract][Full Text] [Related]
13. Bilirubin UDP-glucuronosyltransferase 1A1 (UGT1A1) gene promoter polymorphisms and HPRT, glycophorin A, and micronuclei mutant frequencies in human blood.
Grant DJ; Hall IJ; Eastmond DA; Jones IM; Bell DA
Mutat Res; 2004 May; 560(1):1-10. PubMed ID: 15099818
[TBL] [Abstract][Full Text] [Related]
14. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphism in the phenobarbital-responsive enhancer module of the UDP-glucuronosyltransferase 1A1 gene and irinotecan toxicity.
Kitagawa C; Ando M; Ando Y; Sekido Y; Wakai K; Imaizumi K; Shimokata K; Hasegawa Y
Pharmacogenet Genomics; 2005 Jan; 15(1):35-41. PubMed ID: 15864124
[TBL] [Abstract][Full Text] [Related]
16. The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.
Yao L; Qiu LX; Yu L; Yang Z; Yu XJ; Zhong Y; Yu L
Breast Cancer Res Treat; 2010 Aug; 122(3):879-82. PubMed ID: 20087647
[TBL] [Abstract][Full Text] [Related]
17. Bilirubin UDP-glucuronosyltransferase 1A1 gene polymorphisms: susceptibility to oxidative damage and cancer?
Grant DJ; Bell DA
Mol Carcinog; 2000 Dec; 29(4):198-204. PubMed ID: 11170257
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and prostate cancer risk in Caucasian men.
Karatzas A; Giannatou E; Tzortzis V; Gravas S; Aravantinos E; Moutzouris G; Melekos M; Tsezou A
Cancer Epidemiol; 2010 Jun; 34(3):345-9. PubMed ID: 20308029
[TBL] [Abstract][Full Text] [Related]
19. Validation of rapid polymerase chain reaction-based detection of all length polymorphisms in the UGT 1A1 gene promoter.
Huang CK; Dulau A; Su-Rick CJ; Pan Q
Diagn Mol Pathol; 2007 Mar; 16(1):50-3. PubMed ID: 17471158
[TBL] [Abstract][Full Text] [Related]
20. Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men.
Park J; Chen L; Ratnashinge L; Sellers TA; Tanner JP; Lee JH; Dossett N; Lang N; Kadlubar FF; Ambrosone CB; Zachariah B; Heysek RV; Patterson S; Pow-Sang J
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1473-8. PubMed ID: 16896035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
